Zobrazeno 1 - 10
of 83
pro vyhledávání: '"C, Aquaviva"'
Autor:
Anne Vassault, Gilbert Briand, François Labarthe, François Feillet, P. de Lonlay, Christine Vianey-Saban, C Aquaviva, Brigitte Chabrol, Dries Dobbelaere, R Garnotel, Julien Baruteau, E Jeannesson, et sous l’égide de la Sfeim, David Cheillan, Vassili Valayanopoulos, Hélène Ogier
Publikováno v:
Archives de Pédiatrie. 19:184-193
MCAD deficiency is the most common fatty acid oxidation disorder, with the prevalence varying from 1/10,000 to 1/27,000 in the countries adjacent to France. As the High Authority for Health has recently proposed including MCAD deficiency in the panel
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gaetan Lesca, Nicolas Chatron, Audrey Labalme, C. Francannet, V. Desportes, Patrick Edery, C. Aquaviva, Damien Sanlaville, Anne-Lise Poulat, C. Saban, Marianne Till, Audrey Putoux, Caroline Schluth-Bolard, M. Faoucher
Publikováno v:
European Journal of Paediatric Neurology. 21:e63
Autor:
F, Feillet, H, Ogier, D, Cheillan, C, Aquaviva, F, Labarthe, J, Baruteau, B, Chabrol, P, de Lonlay, V, Valayanopoulos, R, Garnotel, D, Dobbelaere, G, Briand, E, Jeannesson, A, Vassault, C, Vianey-Saban
Publikováno v:
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 19(2)
MCAD deficiency is the most common fatty acid oxidation disorder, with the prevalence varying from 1/10,000 to 1/27,000 in the countries adjacent to France. As the High Authority for Health has recently proposed including MCAD deficiency in the panel
Publikováno v:
Revue Neurologique. 168:296-297
Publikováno v:
Clinical Genetics. 80:598-599
Autor:
T, Bienvenu, I, Souville, K, Poirier, C, Aquaviva, L, Burglen, J, Amiel, B, Héron, A, Kaminska, P, Couvert, C, Beldjord, J, Chelly
Publikováno v:
Human mutation. 18(3)
Rett syndrome (RTT) is a severe progressive neurological disorder that affects almost exclusively females. The gene responsible for this disorder, MECP2, was recently identified by candidate gene strategy. Mutations were detected in 70-85% of RTT cas
Autor:
I Souville, J Steffann, H.H. Ropers, Sylvain Briault, Chantal Gendrot, B Cherif, Alain Verloes, H G Yntema, Jean-Pierre Fryns, J Chelly, A C Le Fevre, C Moraine, C Aquaviva, Philippe Couvert, des Portes, Christian R. Andres, K Poirier, T Bienvenu
Publikováno v:
Human Molecular Genetics, 10, 941--6
Scopus-Elsevier
Human Molecular Genetics, 10, 9, pp. 941--6
Scopus-Elsevier
Human Molecular Genetics, 10, 9, pp. 941--6
Item does not contain fulltext Following the recent discovery that the methyl-CpG binding protein 2 (MECP2) gene located on Xq28 is involved in Rett syndrome (RTT), a wild spectrum of phenotypes, including mental handicap, has been shown to be associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7969897d9d58a9cd3df857545705124c
http://hdl.handle.net/2066/186849
http://hdl.handle.net/2066/186849
Autor:
C, Salvat, C, Aquaviva, I, Jariel-Encontre, P, Ferrara, M, Pariat, A M, Steff, S, Carillo, M, Piechaczyk
Publikováno v:
Molecular biology reports. 26(1-2)
The c-Fos and c-Jun oncoproteins and the p53 tumor suppressor protein are short-lived transcription factors. Several catabolic pathways contribute to their degradation in vivo. c-Fos and c-Jun are thus mostly degraded by the proteasome, but there is
Publikováno v:
The Journal of rheumatology. 25(7)
To determine a pharmacokinetic procedure (Bayesian method) for estimation of methotrexate (MTX) clearance, using only 2 blood samples, in outpatients with rheumatoid arthritis treated with low dose intramuscular (i.m.) MTX.Population pharmacokinetic